| Spirig HealthCare AG - Terbinafin Spirig HC 250 mg, Tabletten |
| 57509 | | 02 | | Terbinafin Spirig HC 250 mg | | Tabletten | | D01BA02 | | Terbinafine | | 24.02.2006 | | |
|
| Composition |
| terbinafinum 250 mg ut terbinafini hydrochloridum, cellulosum microcristallinum, hypromellosum, carboxymethylamylum natricum A corresp. natrium 1.256-1.884 mg, silica colloidalis anhydrica, magnesii stearas pro compresso. |
| Packungsbestandteile |
| Tablets | | | | | Active Agent | Dose |
|---|
| Terbinafine | 250 mg |
| | BAG: Active Agent | Dose |
|---|
| Terbinafine | 250 mg |
| | | | Inactive agents |
|---|
| Carboxymethylamylum Natricum A | | Cellulosum Microcristallinum | | Hypromellosum | | Magnesii Stearas pro Compresso | | Silica Colloidalis Anhydrica |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 008 | 14 | PR | PR | B | | Yes | | 009 | 28 | PR | PR | B | | Yes |
|
